Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3 (bibtex)

by Modest, D P, Denecke, T, Pratschke, J, Ricard, I, Lang, H, Bemelmans, M, Becker, T, Rentsch, M, Seehofer, D, Bruns, C J, Gebauer, B, Modest, H I, Held, S, Folprecht, G, Heinemann, V and Neumann, U P

Reference:

Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3 (Modest, D P, Denecke, T, Pratschke, J, Ricard, I, Lang, H, Bemelmans, M, Becker, T, Rentsch, M, Seehofer, D, Bruns, C J, Gebauer, B, Modest, H I, Held, S, Folprecht, G, Heinemann, V and Neumann, U P), In Eur. J. Cancer, volume 88.

Bibtex Entry:

@Article{Modest2018-nh,
  Author          = {Modest, D P and Denecke, T and Pratschke, J and Ricard,
                    I and Lang, H and Bemelmans, M and Becker, T and Rentsch,
                    M and Seehofer, D and Bruns, C J and Gebauer, B and
                    Modest, H I and Held, S and Folprecht, G and Heinemann, V
                    and Neumann, U P},
  Title           = {Surgical treatment options following chemotherapy plus
                    cetuximab or bevacizumab in metastatic colorectal
                    cancer-central evaluation of {FIRE-3}},
  JournalTitle    = {Eur. J. Cancer},
  Addendum        = preliminarywork,
  Date            = {2018},
  DOI             = {10.1016/j.ejca.2017.10.028},
  Keywords        = {Neumann-Selection},
  Pages           = {77--86},
  Volume          = {88}
}